Health and Healthcare
Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD
The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed bag. Some of the short interest indications doesn’t really look like the short sellers were making the right moves, but time will be the true judge. Here are the key NASDAQ biotech short interest numbers:
Stock (Ticker MAY APRIL CHANGE
Amgen (AMGN) 25.59M 27.99M -8.5%
Gilead (GILD) 12.99M 13.57M -4.2%
Celgene (CELG) 25.9M 24.6M 5%
Genzyme (GENZ) 7.05M 6.75M 4.5%
Medimmune (MEDI) 20.5M 17.2M 18.8%
Biogen-Idec (BIIB) 9.61M 9.09M 5.7%
Amylin Pharma (AMLN) 18.7M 20.0M -6.4%
Imclone (IMCL) 6.26M 7.89M -20.6%
Dendreon (DNDN) 41.6M 33.9M 22.9%
Northfield (NFLD) 6.24M 6.62M -5.7%
Jon C. Ogg
May 25, 2007
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.